Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SSR1 antibody (N-Term)

The Rabbit Polyclonal anti-SSR1 antibody has been validated for WB, IHC and ELISA. It is suitable to detect SSR1 in samples from Human.
Catalog No. ABIN2387321

Quick Overview for SSR1 antibody (N-Term) (ABIN2387321)

Target

See all SSR1 Antibodies
SSR1 (Signal Sequence Receptor, alpha (SSR1))

Reactivity

  • 23
  • 11
  • 7
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Human

Host

  • 17
  • 6
Rabbit

Clonality

  • 19
  • 4
Polyclonal

Conjugate

  • 23
This SSR1 antibody is un-conjugated

Application

  • 23
  • 14
  • 8
  • 6
  • 4
  • 3
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Binding Specificity

    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    Translocon-associated Protein Subunit alpha, NT (SSR1, TRAP-alpha, Signal Sequence Receptor Subunit alpha, SSR-alpha, SSR1, TRAPA, PSEC0262)

    Purification

    Purified by ammonium sulfate precipitation.

    Immunogen

    Synthetic peptide selected from the N-terminal region of human SSR1 (KLH).

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    SSR1 (Signal Sequence Receptor, alpha (SSR1))

    Alternative Name

    Translocon-Associated Protein Subunit alpha

    NCBI Accession

    NP_003135

    UniProt

    P43307

    Pathways

    ER-Nucleus Signaling
You are here:
Chat with us!